Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-22-008106

Chairman & CEO sold 19,875 shares at an average $86.96 ($1,728,247)

  • Chairman & CEO acquired 29,375 shares (option exercise)
  • Chairman & CEO gave 9,500 shares (gift)
  • Chairman & CEO gave 9,500 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Chairman & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-14 Exercise or conversion : show line 1 in the form +29,375 $35.20 $1,033,903 186,727.82 D
2022-06-14 Sale : show line 2 in the form −3,054 $87.92 $268,508 183,673.82 D
2022-06-14 Sale : show line 3 in the form −6,714 $86.24 $579,015 176,959.82 D
2022-06-14 Gift : show line 4 in the form −9,500 167,459.82 D
2022-06-14 Sale : show line 5 in the form −10,107 $87.14 $880,724 157,352.82 D
2022-06-14 Gift : show line 6 in the form +9,500 3,416,017 I
Open-market sales · 19,875 sh · avg $86.96 · $1,728,247

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-06-14 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Acquire) −29,375 $35.20 2023-05-11 29,375 323,125 D
Loading xslF345X03/doc4.xml…